Skip to content

Clinical trials

Enrolling by invitation Phase 3 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Enrolling by invitation Country / region: Germany Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20214
20224
20237
20243
202510

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
UCB Biopharma SRL2
United Therapeutics2
Vertex Pharmaceuticals Incorporated2
Viatris Innovation GmbH2
AstraZeneca1
Astria Therapeutics, Inc.1
Avidity Biosciences, Inc.1
BioCryst Pharmaceuticals1
BioMarin Pharmaceutical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angioedemas, Hereditary3
Epilepsy3
Seizures3
Connective Tissue Diseases2
Lupus Erythematosus, Systemic2
Myotonic Dystrophy2
Amyloidosis1
Anemia, Sickle Cell1
Angioedema1
Asthma1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.